AOD9604 is a synthetic truncated peptide fragment corresponding to amino acid 177?191 of human growth hormone. It retains the fat?targeting biological activity of GH fragment, while showing minimal effect on growth?promoting pathway. This peptide is widely adopted in pre?clinical research focusing on fat metabolism regulation, lipolysis mechanism, lipid turnover and energy metabolism studies.

AOD9604 is manufactured by solid?phase peptide synthesis with rigorous process control. Every production batch undergoes HPLC purity testing and MS molecular weight confirmation. Full set of documentation including COA, HPLC and MS reports can be provided on request. Lyophilized powder is sealed in inert?gas filled glass vials to prevent moisture absorption and oxidative degradation during transportation.

AOD9604 corresponds to the C?terminal bioactive fragment of human growth hormone, commonly referred to as Tyr?hGH 177?191. This peptide contains a critical intramolecular disulfide bridge, which locks its spatial conformation and supports its unique biological profile in research settings. Unlike many GH?related analogs, this molecule is studied for its potential influence on fat breakdown pathways, with research focusing on metabolic responses independent of IGF?1 elevation.

Our AOD9604 is manufactured by advanced solid?phase synthesis, followed by multi?stage chromatographic purification to remove truncated sequences, oxidation impurities and residual reagents. Every production lot undergoes full HPLC profiling together with mass spectrometry confirmation, guaranteeing correct molecular mass and low impurity levels for reliable experimental repeatability. Researchers mainly deploy this compound for adipocyte model assays, metabolic phenotype observation, and comparative biochemical testing of lipid regulatory pathways.

When preparing working solutions, users can reconstitute lyophilized powder with aqueous solvents matching experimental requirements. To preserve structural integrity, lyophilized material must be kept frozen at ?20 °C under dry and dark conditions. Frequent temperature fluctuation and freeze?thaw cycles will trigger disulfide?bond oxidation and peptide deterioration. Once dissolved, the prepared solution should be kept refrigerated and consumed promptly.